CID HoldCo (DAIC) director Sheldon Paul exits board and tech committee

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

CID HoldCo, Inc. reported that on March 19, 2026, Dr. Sheldon Paul resigned from its board of directors and from the Cybersecurity and Technology Committee, effective immediately. His term had been scheduled to run until the annual stockholder meeting on April 30, 2026. The board’s Nominating and Corporate Governance Committee plans to begin searching for a new independent director to fill the vacancy after that meeting.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Understanding 8-K Material Events →

03/25/2026 - 04:44 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 19, 2026

CID HoldCo, Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware

001-42711

99-2578850

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

5661 S Cameron St, Suite 100, Las Vegas, Nevada		89118
(Address of Principal Executive Offices)		(Zip Code)

(303)-332-4122

(Registrant’s telephone number, including area code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 19, 2026, Dr. Sheldon Paul notified the board of directors (the “Board”) of CID HoldCo, Inc., a Delaware corporation (the “Company”), of his intention to resign from the Board and the Cybersecurity and Technology Committee, effective immediately. Dr. Paul was one of two directors whose terms were scheduled to expire at the Company's annual meeting of stockholders to be held on April 30, 2026, and his nomination for re-election had been under consideration in the normal course of the Board's governance processes at the time of his resignation.

The Board’s Nominating and Corporate Governance Committee intends to commence a search for a new independent director to fill the vacancy caused by Dr. Paul’s resignation following the Company’s annual meeting of stockholders.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CID HoldCo, Inc.

Date: March 25, 2026	By:	/s/ Edmund Nabrotzky
		Edmund Nabrotzky
		President and Chief Executive Officer

Source: View Original Filing on SEC EDGAR

FAQ

What did CID HoldCo, Inc. (DAIC) announce in this 8-K filing?

CID HoldCo, Inc. announced that director Dr. Sheldon Paul resigned from the board and the Cybersecurity and Technology Committee, effective March 19, 2026. His departure creates a board vacancy that will be addressed after the upcoming annual stockholder meeting.

When did DAIC director Dr. Sheldon Paul resign from CID HoldCo’s board?

Dr. Sheldon Paul resigned from CID HoldCo’s board of directors on March 19, 2026, effective immediately. His resignation also covered his role on the Cybersecurity and Technology Committee, leaving a vacancy the company plans to fill with a new independent director.

What committee role did Dr. Sheldon Paul leave at CID HoldCo (DAIC)?

Along with his board seat, Dr. Sheldon Paul resigned from CID HoldCo’s Cybersecurity and Technology Committee. This removes his involvement in overseeing technology and cybersecurity matters at the company, and the board intends to recruit another independent director to assume board responsibilities.

Was Dr. Sheldon Paul’s CID HoldCo (DAIC) board term close to expiring?

Yes. Dr. Paul was one of two directors whose terms were scheduled to expire at the annual stockholder meeting on April 30, 2026. His nomination for re-election was under normal board consideration when he chose to resign effective immediately instead of standing for another term.

How will CID HoldCo (DAIC) handle the board vacancy after Dr. Paul’s resignation?

CID HoldCo’s Nominating and Corporate Governance Committee plans to start a search for a new independent director after the April 30, 2026 annual stockholder meeting. This search is intended to fill the vacancy created by Dr. Paul’s immediate resignation from the board and committee.

Who signed the DAIC 8-K reporting Dr. Sheldon Paul’s resignation?

President and Chief Executive Officer Edmund Nabrotzky signed the 8-K on behalf of CID HoldCo, Inc. His signature formally confirms the company’s disclosure of Dr. Sheldon Paul’s immediate resignation and the board’s plan to conduct an independent director search following the annual meeting.

Filing Exhibits & Attachments

3 documents